<table style="border-collapse: collapse; width: 100%;">
<tbody>
<tr>
<td style="width: 30.9256%;">
<h3><img class="alignnone size-full wp-image-6545" src="https://microbiozindia.com/wp-content/uploads/2020/07/Untitled-design-1.png" alt="" width="203" height="117" /></h3>
</td>
<td style="width: 69.0744%;">
<h3>Gilead to evaluate remdesivir in pediatric Covid-19 patients</h3>
Gilead Sciences is set to direct a Phase II/III clinical preliminary of its investigational antiviral medication remdesivir to treat pediatric patients hospitalized with Covid-19. <span style="color: #ff6600;"><a style="color: #ff6600;" href="https://microbiozindia.com/pharma-news/gilead-to-evaluate-remdesivir-in-pediatric-covid-19-patients/">Read more..</a></span></td>
</tr>
<tr>
<td style="width: 30.9256%;">
<h3><img class="alignnone size-full wp-image-6547" src="https://microbiozindia.com/wp-content/uploads/2020/07/Untitled-design-3.png" alt="" width="203" height="117" /></h3>
</td>
<td style="width: 69.0744%;">
<h3>Liquid aspiration in biosafety cabinets</h3>
Safe and contamination-free: The fluid aspiration systems BVC are the perfect solution for safe, sensitive, and efficient aspiration of cell culture supernatants.</td>
</tr>
<tr>
<td style="width: 30.9256%;"><img class="alignnone size-full wp-image-6546" src="https://microbiozindia.com/wp-content/uploads/2020/07/Untitled-design-2.png" alt="" width="203" height="117" /></td>
<td style="width: 69.0744%;">
<h3>Wine-Profiling™ 4.0 from Bruker proves product authenticity to safeguard brand reputation</h3>
New Wine-Profiling™ module from Bruker assures origin, variety and authenticity to protect winemakers, associations, distributors and regulators.Bruker has launched a powerful new Wine-Profiling™ module in its FoodScreener™</td>
</tr>
<tr>
<td style="width: 30.9256%;"><img class="alignnone size-full wp-image-6548" src="https://microbiozindia.com/wp-content/uploads/2020/07/Untitled-design-4.png" alt="" width="203" height="117" /></td>
<td style="width: 69.0744%;">
<h3>Sanofi eyes endorsement of COVID-19 immunization by first 50% of 2021</h3>
French drugmaker Sanofi SA, said on June 23, it hopes to get endorsement for the potential COVID-19 antibody it is creating with Britain’s GlaxoSmithKline Plc by the primary portion of one year from now, quicker than recently envisioned.<span style="color: #ff6600;"><a style="color: #ff6600;" href="https://microbiozindia.com/pharma-news/sanofi-eyes-endorsement-of-covid-19-immunization-by-first-50-of-2021/">Read more..</a></span></td>
</tr>
</tbody>
</table>